Advertisement
Screener

Niki BioSolutions, Inc. (NIKI) Form 20-F: Annual report of foreign private issuer

Niki BioSolutions, Inc. Form 20-F: Annual report of foreign private issuer

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2026-03-27: Form 20-F; Period of report 2025-12-31; Description ANNUAL REPORT; Document ea0281612-20f_aptorum.htm.
  • 2025-04-30: Form 20-F; Period of report 2024-12-31; Description ANNUAL REPORT; Document ea0238205-20f_aptorum.htm.
  • 2024-04-30: Form 20-F; Period of report 2023-12-31; Description ANNUAL REPORT; Document ea0203681-20f_aptorum.htm.
  • 2023-04-28: Form 20-F; Period of report 2022-12-31; Description ANNUAL REPORT; Document f20f2022_aptorumgroup.htm.
FiledFormPeriod of reportDescriptionDocument
2026-03-2720-F2025-12-31ANNUAL REPORTea0281612-20f_aptorum.htm
2025-04-3020-F2024-12-31ANNUAL REPORTea0238205-20f_aptorum.htm
2024-04-3020-F2023-12-31ANNUAL REPORTea0203681-20f_aptorum.htm
2023-04-2820-F2022-12-31ANNUAL REPORTf20f2022_aptorumgroup.htm
2022-04-2920-F2021-12-31ANNUAL REPORTf20f2021_aptorum.htm
2021-04-1920-F2020-12-31ANNUAL REPORTf20f2020_aptorumgrouplimited.htm
2020-04-2920-F2019-12-31ANNUAL REPORTf20f2019_aptorumgroup.htm
2019-04-1520-F2018-12-31ANNUAL REPORTf20f2018_aptorumgroup.htm